ESC2024 Premium Access

The effects of angiotensin receptor-neprilysin inhibitors on clinical outcomes in heart failure with mildly reduced or preserved ejection fraction: real-world evidence from the CCA Database-HF Center

Congress Presentation

About the speakers

Doctor Zhonglei Xie

Zhongshan Hospital, Shanghai (China)
0 follower

Professor Jingmin Zhou

Zhongshan Hospital, Shanghai (China)
1 presentation
0 follower

6 more presentations in this session

Beta-blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction

Speaker: Doctor S. Matsumoto (Tokyo, JP)

Thumbnail

Systematic review and meta-analysis on the effects of physical activity-based interventions on frailty status and clinical outcomes in adults with long-term cardiac conditions.

Speaker: Ms H. Waterhouse (Leicester, GB)

Thumbnail

Assessing the practicality of a novel heart failure therapeutic score (QUAD Score) for drug optimisation in heart failure with a reduced ejection fraction

Speaker: Doctor A. Ganapathy (Basildon, GB)

Thumbnail

Short-term effects on sacubitril/valsartan therapy on right ventricle work and mechanics in patients with heart failure and reduced ejection fraction

Speaker: Doctor J. Ottela (Turku, FI)

Thumbnail

Cardiovascular mortality with oral potassium-binders in patients with CKD and heart failure

Speaker: Doctor H. Barzkar (Dallas, US)

Thumbnail

Access the full session

Heart failure: drug therapy and multidisciplinary care

Speakers: Doctor Z. Xie, Professor J. Zhou, Doctor S. Matsumoto, Ms H. Waterhouse, Doctor A. Ganapathy...
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations